Year in Lipid Disorders, Volume 2

Name: Year in Lipid Disorders, Volume 2
Availability: OutOfStock
ISBN: 9781846920615

ISBN-10: 1846920612

ISBN-13: 9781846920615

Edition: 2010

Authors: Peter P. Toth

List price: $99.95

30 day, 100% satisfaction guarantee!

Out of stock

We're sorry. This item is currently unavailable.

what's this?

Rush Rewards U
Members Receive:

You have reached 400 XP and carrot coins. That is the daily max!

Description:

The Year in Lipid Disorders presents the inquiring physician with an up-to-date insight into the latest research on dyslipidaemias, and the implications of this research for daily clinical practice, highlighting throughout the key role of lipid disorders in developing atherosclerosis and heart disease. The book provides an overview of the latest developments in this complex field by reviewing the most significant papers published in the leading medical journals, and analyses in depth recent results of key clinical trials. Book jacket.

Book details

List price: $99.95
Copyright year: 2010
Publisher: Clinical Publishing Services
Publication date: 4/1/2010
Binding: Hardcover
Pages: 332
Size: 6.25" wide x 9.25" long x 1.25" tall
Weight: 1.936
Language: English

Editors and contributors	p. vii
Clinical aspects of atherosclerotic disease	p. 1
PCSK9: Molecular functions, polymorphisms, and risk for atherosclerotic disease	p. 3
Metabolic syndrome, diabetes and cardiovascular risk	p. 24
Diet and exercise in the prevention and treatment of diabetes and coronary heart disease	p. 46
Imaging developments in vascular disease	p. 60
Lipids, lipoproteins and atherosclerosis	p. 79
Ezetimibe: mechanism of action update and recent controversies	p. 81
Oxidative stress, lipoprotein oxidation and atherosclerosis	p. 97
Updating the metabolism of apolipoprotein B-100-containing lipoproteins in dyslipidaemia	p. 118
Triglycerides and atherosclerosis	p. 140
Prevention and treatment strategies	p. 167
The JUPITER Trial: the intersection between inflammation, statin therapy, and risk for cardiovascular events	p. 169
New clinical trials of lipid-regulating agents	p. 186
Statin myopathy	p. 203
Nuclear receptors (PPARs, LXRs and TRs) and their role in regulating lipid metabolism	p. 220
Infection, inflammation and secondary causes of atherosclerosis	p. 241
Inflammation, inflammatory disease, and coronary atherosclerosis	p. 243
Mechanisms of insulin resistance and impact on atherosclerosis	p. 270
Haemostasis-dyslipidaemia interactions in coronary heart disease	p. 288
Acronyms/abbreviations	p. 307
Index of papers reviewed	p. 311
General index	p. 319
Table of Contents provided by Ingram. All Rights Reserved.